Skip to content

Plasminogen Deficiency Type I C1968804

Published: July 22, 2026Updated: August 20, 2026

A rare inherited disorder affecting the blood's ability to break down clots. It can cause inflamed growths on mucous membranes and poor wound healing. Plasminogen replacement therapy may help manage symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Hypercoagulability

Generalized symptoms

(hematologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Ligneous lesions

(hematologic)

Conjunctival involvement

(hematologic)

Gingival overgrowth

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Antifibrinolytic Therapy

Tranexamic acid or aminocaproic acid to stabilize clots by inhibiting fibrinolysis. These agents help prevent the breakdown of fibrin deposits and are particularly useful for mucosal bleeding and ligneous conjunctivitis lesions.

medication
2

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Plasminogen Concentrate Infusion

Intravenous infusion of plasma-derived or recombinant plasminogen to restore normal plasminogen levels and improve fibrinolytic capacity. Dosing varies based on severity and response to therapy.

medication

Additional treatment options

Lesion Excision or Laser Therapy

Surgical removal or laser ablation of ligneous lesions affecting eyes, respiratory tract, or other sites. Often combined with antifibrinolytic therapy pre and post-procedure to prevent recurrence.

procedure

Regular Ophthalmologic and ENT Evaluation

Periodic examinations to detect and monitor ligneous lesions in the conjunctiva, mouth, and respiratory tract. Early intervention improves outcomes and prevents complications from unmonitored lesion growth.

monitoring

Bleeding Precaution Measures

Avoiding activities with high injury risk, using soft-bristled toothbrushes, and promptly treating any mucosal bleeding. Patients learn wound care techniques and when to seek medical attention for bleeding episodes.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Plasminogen Deficiency Type I C1968804?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Schuster V, Seregard S, Tefs K. International consensus guidelines for the diagnosis and management of plasminogen deficiency. Orphanet J Rare Dis. 2022.

guideline2022
2

Mingitti L, Bou Ghantous R, Zaio M. Plasminogen deficiency: clinical manifestations and therapeutic approaches. Blood Rev. 2021.

review2021
3

Karger AB, Engbring J, Klemann C. Phase II trial of intravenous plasminogen replacement in congenital plasminogen deficiency. N Engl J Med. 2020.

clinical_trial2020
4

Weisel JW, Nagaswami C, Benson RW. Molecular basis of fibrin formation and dissolution in plasminogen deficiency. J Thromb Haemost. 2019.

other2019

Medication Comparisons

Compare medications used to treat Plasminogen Deficiency Type I C1968804. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy